Medication Treatments

Mainstreaming Addiction Treatment Act Revived in Congress
The bill, first proposed in 2019, would eliminate the requirement that practitioners obtain a separate “X-waiver” through DEA to prescribe buprenorphine for treating substance use disorders.
MDMA-Assisted Psychotherapy Shows Promise in Treatment for Alcohol Addiction
MDMA-assisted psychotherapy for the treatment of alcohol use disorder was found to improve psychosocial functioning with no unexpected adverse events in a clinical trial conducted by London-based Awakn Life Sciences.
Patients Taking Opioids for Chronic Pain More Likely to Live in Disadvantaged Areas
A study that was presented this month at the Association of Academic Psychiatrists Annual Meeting suggests that patients being treated for pain with chronic opioid therapy are more likely to live in socially disadvantaged areas and self-report feelings of anxiety, depression and pain more frequently.
In-Office Provision of Buprenorphine Ups Retention Rates for OUD Patients in Study
A study by Cordant Health Solutions and Northwest Integrated Health found that OUD patients who had been prescribed buprenorphine demonstrated higher retention rates and improved health outcomes when receiving medication at office visits instead of retail pharmacies.
Pa. Bill to Add Buprenorphine Prescribing Restrictions Revived
A Pennsylvania state senator has announced plans to resuscitate a bill that would create new regulations around the provision of buprenorphine in the state.
Spectrum to Provide MAT Services for Incarcerated Individuals in Massachusetts
Spectrum Health Systems announced that it has been awarded a four-year, $43.5 million contract by the Massachusetts Department of Correction to provide medication-assisted treatment to incarcerated offenders.
FDA Seeks Public Input on Patient-Focused Drug Development for Stimulant Use Disorder
The FDA will conduct a virtual public meeting on patient-focused drug development for stimulant use disorder on Oct. 6, and is seeking input from individuals and families impacted by stimulant use.
Temple Researchers Receive NIDA Grant to Study Cocaine Addiction Treatment
Researchers at Temple University have received a $1.77 million grant from the National Institute on Drug Abuse to study the effects of a therapy for the treatment of cocaine use disorder, according to a media report.
1 in 5 Emergency Dept. Physicians Ready to Offer Buprenorphine
A Yale study of 400 clinicians found that just 21% of emergency department clinicians say they are prepared to prescribe buprenorphine for the treatment of opioid use disorder.
Elevate Spotlight: Best Practices in Opioid Addiction Treatment
With the far reach of the opioid epidemic and the high comorbidity of opioid addiction with other psychiatric disorders, the session will be relevant to all attendees, not just those in addiction medicine.
NCAD West: Prescription Opioid Misuse Drops, but Providers Need to Stay Vocal
During the opening plenary of NCAD West on Thursday, Colorado Consortium for Prescription Drug Abuse director Rober Valuck, PhD, RPh, FNAP, implored attendees to aggressively fight barriers to treatment, scrutinize their own work, and learn from their peers.
Back to Top